Esmolol reduces anesthetic requirement for skin incision during propofol/nitrous oxide/morphine anesthesia

Anesthesiology

Volumn 86, Issue 2, 1997, Pages 364-371

  Johansen, Jay W ^a   Flaishon, Ronald ^b   Sebel, Peter S ^b  

^a EMORY UNIVERSITY   (United States)

^b NONE

Author keywords

receptor blockade: esmolol; Anesthetic techniques: computer controlled infusion; Anesthetics, intravenous: propofol; Interactions (drug) esmolol propofol

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ESMOLOL; MORPHINE SULFATE; NITROUS OXIDE; PROPOFOL; SUXAMETHONIUM;

ADULT; AGED; ANESTHESIA INDUCTION; ARTICLE; CLINICAL TRIAL; COMPARTMENT MODEL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG MEGADOSE; FEMALE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS ANESTHESIA; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PREMEDICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN INCISION;

ADOLESCENT; ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; ANESTHETICS, INTRAVENOUS; FEMALE; HUMANS; MALE; MIDDLE AGED; MORPHINE; NITROUS OXIDE; PROPANOLAMINES; PROPOFOL;

EID: 0031049846     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-199702000-00011     Document Type: Article

References (51)

1. Leszkovszky G, Tardos L: Some effects of propranolol on the central nervous system. J Pharm Pharmacol 1965; 17:518-19
2. Murmann W, Almirante L, Saccani-Guelfi M: Central nervous system effects of four beta-adrenergic receptor blocking agents. J Pharm Pharmacol 1966; 18:318
3. Hermansen K: Effect of different beta-adrenergic receptor blocking agents on hexobarbital induced narcosis in mice. Acts Pharmacol Toxicol 1969; 27:453-60
4. Bainbridge JG, Greenwood DT: Tranquillizing effects on propranolol demonstrated in rats. Neuropharmacology 1971; 10:453-8
5. Granville-Grossman KL, Turner P: The effect of propranolol on anxiety. Lancet 1966; 1:788-90
6. Waal HJ: Propranolol-induced depression. BMJ 1967; 2:50
7. Miller RD, Way WL, Eger EI: The effects of alpha-methyldopa, reserpine, guanethidine, and iproniazid on minimum alveolar anesthetic requirement (MAC). ANESTHESIOLOGY 1968; 29:1153-8
8. Tanifuji Y, Eger EI II: Effect of isoproterenol and propranolol on halothane MAC in dogs. Anesth Analg 1976; 55:383-7
9. Steffey EP, Eger EI II: The effect of seven vasopressors on halothane MAC in dogs. Br J Anaesth 1975; 47:435-8
10. Johnston RR, Way WL, Miller RD: Alteration of anesthetic requirement by amphetamine. ANESTHESIOLOGY 1972; 36:357-63
11. Eger EI, Saidman LJ, Brandstater B: Minimum alveolar anesthetic concentration: A standard of anesthetic potency. ANESTHESIOLOGY 1965; 26:756-63
12. Saidman LJ, Eger EI: Effect of nitrous oxide and of narcotic premedication on the alveolar concentration of halothane required for anesthesia. ANESTHESIOLOGY 1964; 25:302-6
13. Ausems ME, Hug CC, Stanski DR, Burm AG: Plasma concentrations of alfentanil required to supplement nitrous oxide anesthesia for general surgery. ANESTHESIOLOGY 1986; 65:362-73
14. Sebel PS, Glass PSA, Fletcher JE, Murphy MR, Gallagher C, Quill TJ: Reduction of the MAC of desflurane with fentanyl. ANESTHESIOLOGY 1992; 76:52-9
15. McEwan AI, Smith C, Dyar O, Goodman D, Smith LR, Glass PSA: Isoflurane minimum alveolar concentration reduction by fentanyl. ANESTHESIOLOGY 1993; 78:864-9
16. Westmoreland CL, Sebel PS, Gropper A: Fentanyl or alfentanil decreases the minimum alveolar anesthetic concentration of isoflurane in surgical patients. Anesth Analg 1994; 78:23-8
17. Vinik HR, Bradley Jr EL, Kissin I: Triple Anesthetic Combination: Propofol-Midazolam-Alfentanil. Anesth Analg 1994; 78:354-8
18. Teh J, Short TG, Wong J, Tan P: Pharmacokinetic interactions between midazolam and propofol: An infusion study. Br J Anaesth 1994; 72:62-5
19. Vuyk J, Lim T, Engbers FHM, Burm AGL, Vletter AA, Bovill JG: The pharmacodynamic interaction of propofol and alfentanil during lower abdominal surgery in women. ANESTHESIOLOGY 1995; 83:8-22
20. Smith C, McEwan AI, Jhaveri R, Wilkinson M, Goodman D, Smith LR, Canada AT, Glass PSA: The interaction of fentanyl on the Cp50 of propofol for loss of consciousness and skin incision. ANESTHESIOLOGY 1994; 81:820-8
21. Bührer M, Maitre PO, Hung OR, Ebling WF, Shafer SL, Stanski DR: Thiopental pharmacodynamics, Defining the pseudo-steady-state serum concentration-EEG effect relationship. ANESTHESIOLOGY 1992; 77:226-36
22. Glass PSA, Doherty D, Jacobs JR, Quill TJ: Pharmacokinetic basis of intravenous drug delivery, Bailliere's Clinical Anaesthesiology: Kinetics of Anaesthetic Drugs in Clinical Anaesthesiology. Edited by White PF. London, WB Saunders, 1991. pp 735-75
23. Sum CY, Yacobi A, Kartzinel R, Stampfli H, Davis CS: Kinetics of esmolol, an ultra-short-acting beta Mocker, and of its major metabolite. Clin Pharmacol Ther 1983; 14:427-34
24. de Bruijn NP, Reves JG, Croughwell N, Clements F, Drissel DA: Pharmacokinetics of esmolol in anesthetized patients receiving chronic beta blocker therapy. ANESTHESIOLOGY 1987; 66:323-6
25. Miller DR, Martineau RJ, Wynands JE, Hill J: Bolus administration of esmolol for controlling the haemodynamic response to tracheal intubation: The canadian multicentre trial. Can J Anaesth 1991; 38:849-58
26. Murthy VS, Hwang T, Sandage BW, Laddu A: Esmolol and the adrenergic response to perioperative stimuli. J Clin Pharmacol 1986; 26:A27-A35
27. Parnass SM, Rothenberg DM, Kerchberger JP, Ivankovich AD: A single bolus dose of esmolol in the prevention of intubation-induced tachycardia and hypertension in an ambulatory surgery unit. J Clin Anesth 1990; 2:232-7
28. Gold JI, Sacks DJ, Grosnoff DB, Herrington C, Skillman CA: Use of esmolol during anesthesia to treat tachycardia and hypertension. Anesth Analg 1989; 68:101-4
29. Fuhrman TM, Ewell CL, Pippin WD, Weaver JM: Comparison of the efficacy of esmolol and alfentanil to attenuate the hemodynamic responses to emergence and extubation. J Clin Anesth 1992; 4:444-7
30. Leslie JB: Bolus dose esmolol for anesthesia: Is there a need? J Clin Anesth 1990; 2:215-20
31. Smith I, Hemelrijck JV, White PF: Efficacy of esmolol versus alfentanil as a supplement to propofol-nitrous oxide anesthesia. Anesth Analg 1991; 73:540-6
32. Dixon WJ: The up-and-down method for small samples. Am Assoc J 1965; 60:967-78
33. Plummer GFC: Improved method for the determination of propofol in blood by high-performance liquid chromatography with fluorescence detection. J Chromatogr Biomed Appl 1987; 421:171-6
34. Varvel JR, Donoho DL, Shafer SL: Measuring the predictive performance of computer-controlled infusion pumps. Pharmacokinet Biopharm 1992; 20:63-94
35. Shafer A, Sung M, White PF: Pharmacokinetics and pharmacodynamics of alfentanil infusions during general anesthesia. Anesth Analg 1986; 65:1021-8
36. Davidson JAH, Macleod AD, Howie JC, White M, Kenny GNC: Effective concentration 50 for propofol with and without 67% nitrous oxide, Acta Anaesthesiol Scand 1993; 37:458-64
37. Coates DP, Prys-Roberts C, Spelina KR, Monk CR, Norley I: Propofol ('Diprivan') by intravenous infusion with nitrous oxide: Dose requirements and haemodynamic effects. Postgrad Med J 1985; 61(Suppl):76-9
38. Spelina KR, Coates DP, Monk CR, Prys-Roberts C, Norley I, Turtle MJ: Dose requirements of propofol by infusion during nitrous oxide anaesthesia in man. I. Patients premedicated with morphine sulphate. Br J Anaesth 1986; 58:1080-4
39. Turtle MJ, Cullen P, Prys-Roberts C, Coates D, Monk CR, Faroqui MH: Dose requirements of propofol by infusion during nitrous oxide anaesthesia in man. II: Patients premedicated with lorazepam. Br J Anaesth 1987; 59:283-7
40. Clark DL, Rosner BS: Neurophysiologic effects of general anesthetics: I: The electroencephalogram and sensory evoked responses in man. ANESTHESIOLOGY 1973; 38:564-82
41. Hudson RJ, Stanski DR, Saidman LJ, Meathe E: A model for studying depth of anesthesia and acute tolerance to thiopental, ANESTHESIOLOGY 1983; 59:301-8
42. Scott JC, Ponganis KV, Stanski DR: EEG quantitation of narcotic effect: The comparative pharmacodynamics of fentanyl and alfentanil. ANESTHESIOLOGY 1985; 62:234-41
43. Shafer A, Doze VA, Shafer SL, White PF: Pharmacokinetics and pharmacodynamics of propofol infusions during general anesthesia. ANESTHESIOLOGY 1988; 69:348-56
44. Pavlin DJ, Coda B, Shen DD, Tschanz J, Nguyen Q, Shaffer R, Donaldson G, Jacobson RC, Chapman CR: Effects of combining propofol and alfentanil on ventilation, analgesia, sedation and emesis in human volunteers. ANESTHESIOLOGY 1996; 84:23-37
45. Major E, Aun C, Savege TM, Verniquet AJW, Adam H, Douglas EJ: Influence of sample site on blood concentrations of ICI 35868, Br J Anaesth 1983; 55:371-5
46. Okell RW, Mapleson WW, Vickers MD: Comparison of arterial and arterialized venous concentrations of propofol during infusion of propofol. Br J Anaesth 1991; 67:285-8
47. Laverty R, Taylor KM: Propranolol uptake into the central nervous system and the effect on rat behaviour and amine metabolism. J Pharm Pharmacol 1968; 20:605-9
48. Gorczynski RJ: Basic pharmacology of esmolol. Am J Cardiol 1985: 56:3F-13F
49. Angaran DM, Schultz NJ, Tschida VH: Esmolol hydrochloride: An ultrashort-acting, beta-adrenergic blocking agent. Clin Pharmacol 1986; 5:288-303
50. Amar D, Shamoon H, Frishman WH, Lazar EJ, Salama MD: Effects of labetalol on perioperative stress markers and isoflurane requirements. Br J Anaesth 1991; 67:296-301
51. Stanley TH, deLange S, Boscoe MJ, deBruijn N: The influence of chronic preoperative propranolol therapy on cardiovascular dynamics and narcotic requirements during operation in patients with coronary artery disease, Can Anaesth Soc J 1982; 29:319-24